Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2025-01-15 00:00:00 ET · period of report 2025-01-13 · accession 0001415889-25-001501 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-15 | 2025-01-13 | ANAB | Schmid John P. | Dir | M - OptEx | $6.50 | +42.3K | 25.6K | New | +$275.0K |
| DM | 2025-01-15 | 2025-01-13 | ANAB | Schmid John P. | Dir | M - OptEx | $0.00 | -42.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-13 | M | A | 20,645 | $8.54 | 46,237 | D | — | — | (F1) The exercises reported on this Form 4 for various stock options are expiring in 2025 and the Reporting Person wished to facilitate the exercises of such options before their expiration. The Reporting Person does not intend to currently sell any of the said exercised shares in this Form 4. |
| 2 | Common | Common Stock | 2025-01-13 | M | A | 21,692 | $4.55 | 25,592 | D | — | — | (F1) The exercises reported on this Form 4 for various stock options are expiring in 2025 and the Reporting Person wished to facilitate the exercises of such options before their expiration. The Reporting Person does not intend to currently sell any of the said exercised shares in this Form 4. |
| 3 | Derivative | Stock Option (right to buy) | 2025-01-13 | M | D | 20,645 | $0.00 | 0 | D | $8.54 · — to 2025-11-15 | 20,645 Common Stock | (F2) The option is fully vested. |
| 4 | Derivative | Stock Option (right to buy) | 2025-01-13 | M | D | 21,692 | $0.00 | 0 | D | $4.55 · — to 2025-06-09 | 21,692 Common Stock | (F2) The option is fully vested. |